C-BIOMEX

BiotechnologySeries BSouth Koreacbiomex.com

Latest round

Series B

Last raised

Jun 2022

Total raised

$7.5M

Investors

8

About C-BIOMEX

Based in Gyeongsangbuk-do, South Korea, and founded in 2017, Cbiomex Inc. also known as C-BIOMEX operates as a biopharmaceutical company that is focused on the development of peptide therapeutics., LTD. The company develops theragnostic technology for peptide radioactive treatment and diagnosis for cancer. Through its platform, CUS™, the company is working on radioactive isotopes for cancer cells, based on preclinical data to screen peptides that selectively bind to target substances. Their peptides are designed to have higher stability in blood and greater binding ability and selectivity to target substances, making them more effective than existing drugs. The projects in C-Biomex’s pipeline, as of April 2023, are CBT-001, for kidney cancer, is in late discovery, and CBT-002, for neuroendocrine tumor, CBT-004, for solid cancer, and CBT-005, for achondroplasia, are in early discovery stage.

Who invested in C-BIOMEX

8 investors across 3 rounds

See all investors in C-BIOMEX

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 22, 2022

    Amount

    $5M

    Investors

    Locked

  2. Series A

    Mar 26, 2020

    Amount

    $2.5M

    Investors

    Locked

  3. Seed

    May 1, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about C-BIOMEX

Who invested in C-BIOMEX?

C-BIOMEX has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has C-BIOMEX raised?

C-BIOMEX has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did C-BIOMEX last raise money?

C-BIOMEX's most recent round on record is a Series B, in Jun 2022.

What does C-BIOMEX do?

Based in Gyeongsangbuk-do, South Korea, and founded in 2017, Cbiomex Inc.

Where is C-BIOMEX headquartered?

C-BIOMEX is headquartered in South Korea.

Which VCs invest in companies like C-BIOMEX?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at C-BIOMEX's stage. Their profiles are linked below.

Raising like C-BIOMEX? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.